Get the Stockscreener App
6.65
2.06%
-0.14
After Hours:
6.60
-0.05
-0.75%
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $6.65, with a volume of 2.21M.
It is down -2.06% in the last 24 hours and down -3.34% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$6.79
Open:
$6.85
24h Volume:
2.21M
Relative Volume:
0.87
Market Cap:
$2.46B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-13.85
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
-10.74%
1M Performance:
-3.34%
6M Performance:
+5.22%
1Y Performance:
-10.98%
1-Day Range:
$6.56
$6.87
1-Week Range:
$6.56
$7.45
52-Week Range:
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.65 | 2.52B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
125.08 | 54.31B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.08 | 51.02B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.24 | 45.11B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.41 | 35.98B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
469.77 | 20.15B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026 - The Malaysian Reserve
Bausch Health Cos Inc. (NYSE:BHC) Sees Significant Decrease in Short Interest - MarketBeat
Bull Bear: Is Bausch Health Companies Inc showing insider buyingMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Trend Report: Is Bausch Health Companies Inc backed by strong institutional buyingJuly 2025 EndofMonth & Growth Focused Entry Point Reports - baoquankhu1.vn
Wall Street Zen Downgrades Bausch Health Cos (NYSE:BHC) to Buy - MarketBeat
Loss Report: Whats the outlook for Bausch Health Companies Incs sectorJuly 2025 Momentum & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Bausch Health Companies (TSE:BHC) Trading Down 2.3%Here's What Happened - MarketBeat
Bausch Health sets 2025 outlook at the higher end of the prior range - MSN
Stop Loss: Is Bausch Health Companies Inc likely to announce a buybackMarket Movement Recap & Free High Return Stock Watch Alerts - baoquankhu1.vn
Bausch Health reaffirms 2025 outlook (BHC:NYSE) - Seeking Alpha
Bausch Health Brief: Management Expects to Reaffirm FY25 Guidance at Higher End of Range for Itself Excluding Bausch + Lomb As Provided In October - marketscreener.com
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring the 563.16% ROE and Future Potential - DirectorsTalk Interviews
Bausch Health Cos Inc. (NYSE:BHC) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Will Bausch Health Companies Inc. stock gain from green policiesWeekly Gains Summary & Entry Point Strategy Guides - Улправда
Is Bausch Health Companies Inc. stock cheap by valuation metricsJuly 2025 Update & Reliable Entry Point Trade Alerts - ulpravda.ru
Why Bausch Health Companies Stock Rocketed 11% Higher Today - MSN
Bausch Health: Solta’s Global Expansion Playbook Is Working—But Can China’s Slowdown Be Offset? - Smartkarma
How to contact the Daily Bulletin - FinancialContent
Bausch Health Cos Inc. $BHC Shares Sold by SG Americas Securities LLC - MarketBeat
Is Bausch Health Companies Inc. (BVF) stock a defensive play amid uncertaintyTreasury Yields & Daily Oversold Bounce Ideas - ulpravda.ru
Is Bausch Health Companies Inc. stock a safe haven assetGDP Growth & Fast Exit Strategy with Risk Control - ulpravda.ru
Will Bausch Health Companies Inc. stock continue dividend increasesJuly 2025 Institutional & Verified Technical Trade Signals - ulpravda.ru
Will Bausch Health Companies Inc. stock split again soonVolume Spike & Short-Term Trading Opportunity Alerts - ulpravda.ru
Why Bausch Health Companies Inc. stock is in analyst buy zoneRecession Risk & Free Safe Entry Trade Signal Reports - ulpravda.ru
Analysis Recap: Is Bausch Health Companies Inc. stock a safe haven assetJuly 2025 Outlook & Weekly Watchlist for Consistent Profits - ulpravda.ru
Eye Health Supplements Market 2026 Forecast: In-Depth Industry - openPR.com
Bausch Health Companies Inc. Common Stock (TSX: BHC - FinancialContent
Rally Mode: Is Bausch Health Companies Inc stock a safe haven assetWeekly Market Report & Daily Entry Point Trade Alerts - moha.gov.vn
Will Bausch Health Companies Inc. stock deliver shareholder valueMomentum Trading Signals & Today’s Picks, Tomorrow’s Winners - ulpravda.ru
Truist Securities Adjusts Price Target on Bausch Health to $8 From $7, Maintains Hold Rating - MarketScreener
Does Bausch Health (BHC) Extending Secured Debt to 2032 Clarify or Complicate Its Deleveraging Path? - simplywall.st
Bausch Health Companies Inc. (BHC) Stock Analysis: A Closer Look at Its Potential in the Healthcare Sector - DirectorsTalk Interviews
Bausch & Lomb drops after ending sales process - MSN
A Look At Bausch Health (BHC) Valuation After Its US$1.6b Debt Refinancing - Sahm
Rosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - The AI Journal
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Trade Recap: Is Bausch Health Companies Inc stock overvalued by current metricsJuly 2025 EndofMonth & Verified Entry Point Signals - moha.gov.vn
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises - MSN
Bausch Health (NYSE: BHC) unit revises $2.8B term loans, extends 2028 debt to 2031 - Stock Titan
Bausch Health (BHC) director John Paulson discloses RSUs and large shareholdings - Stock Titan
Bausch Health (BHC) director reports 4,586 RSUs and 38,408 shares owned - Stock Titan
Bausch Health (BHC) director granted 989 RSUs as quarterly board compensation - Stock Titan
Looking Into Bausch Health Companies Inc's Recent Short Interest - Benzinga
Japan Dermatology Devices Market is Driven by Skin Health - openPR.com
Bausch Health Signs Multiple Material Agreements - TradingView — Track All Markets
Bausch Health (NYSE: BHC) swaps into $1.6B 10% 2032 secured notes - Stock Titan
BHC SEC FilingsBausch Health Companies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Q2 EPS Estimate for Bausch Health Cos Boosted by Analyst - MarketBeat
What is Zacks Research's Estimate for TSE:BHC Q4 Earnings? - MarketBeat
Bausch Health (BHC) Is Up 5.3% After US$1.6 Billion Debt ExchangeHas The Bull Case Changed? - Yahoo Finance
Bausch Health announces completion of $1.6 billion debt exchange offer By Investing.com - Investing.com Nigeria
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
9.91%
2.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):